All News about Incyte Corp
The Analyst Verdict: Incyte In The Eyes Of 8 Experts
February 14, 2024
Via Benzinga
Expert Ratings for Incyte
December 13, 2023
Via Benzinga
Incyte Gains Exclusive Global Development and Commercialization Rights to Tafasitamab (Monjuvi®)
February 05, 2024
From Incyte
Via Business Wire
Via Benzinga
Incyte to Report Fourth Quarter and Year-End 2023 Financial Results
January 23, 2024
From Incyte
Via Business Wire
S&P 500's Hidden Gems: 27 Stocks With 30%+ Upside Potential According To Wall Street Analysts Targets
December 07, 2023
Via Benzinga
Topics
Stocks
Exposures
US Equities
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.